Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Gilead Sciences - Wikipedia

   en.wikipedia.org/wiki/Gilead_Sciences

   Gilead Sciences. Gilead Sciences, Inc. ( / ˈɡɪliəd /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

3. John C. Martin (businessman) - Wikipedia

   en.wikipedia.org/wiki/John_C._Martin_(businessman)

   John Charles Martin(May 7, 1951 – March 30, 2021) was an American billionairebusinessman, and the former executive chairman (2016–2018) and CEO(1996–2016) of the American biotechnology companyGilead Sciences. [2][3]He joined Gilead Sciences in 1990 as vice president for research and development. [4][1]Gilead is known for developing drugs ...

4. US FDA approves Gilead's liver disease drug - AOL

   www.aol.com/news/us-fda-approves-gileads-liver...

   (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' liver disease treatment, Livdelzi, which it gained through a $4.3 billion buyout deal for CymaBay ...

5. John F. Milligan - Wikipedia

   en.wikipedia.org/wiki/John_F._Milligan

   John F. Milligan is an American former executive who was the CEO of Gilead Sciences, a biotechnology company based in the United States from March 2016. He was previously appointed President of the company and had maintained that role since May 2008. [1] He held various other positions during his tenure with Gilead including COO and CFO and ...

6. Gilead's long-acting HIV drug superior to daily pill Truvada ...

   www.aol.com/news/gileads-long-acting-hiv-drug...

   (Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill ...

7. Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript - AOL

   www.aol.com/gilead-sciences-gild-q2-2024...

   Motley Fool Transcribing, The Motley Fool. August 8, 2024 at 9:45 PM. Logo of jester cap with thought bubble. Image source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q2 2024 Earnings Call ...